Recruiting Thrombocytopenia Studies in Seattle
About Thrombocytopenia Clinical Trials in Seattle
Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.
There are currently 1 thrombocytopenia clinical trials recruiting participants in Seattle, WA. These studies are seeking a combined 56 participants. Research is being sponsored by Incyte Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thrombocytopenia Clinical Trials in Seattle — FAQ
Are there thrombocytopenia clinical trials in Seattle?
Yes, there are 1 thrombocytopenia clinical trials currently recruiting in Seattle, WA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Seattle?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.
Are clinical trials in Seattle free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.
What thrombocytopenia treatments are being tested?
The 1 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for thrombocytopenia.
Data updated October 15, 2026 from ClinicalTrials.gov